[1]
Değertekin, B. et al. 2020. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. Turkish Journal of Gastroenterology. 31, 12 (Jan. 2020), 883–893. DOI:https://doi.org/10.5152/tjg.2020.20696.